Symbols

QTTB

Q32 Bio·NASDAQ

--(--)

QTTB fundamentals

QTTB Q2 2025 Earnings

Q32 Bio (QTTB) released its earnings on Aug 6, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.78 (YoY +45.07%), beat estimates.

Revenue / YoY

EPS / YoY

-0.78

+45.07%

Report date

Aug 6, 2025

Earnings Call

4:00 PM on Aug 6, 2025

Meeting link.

Earnings

EPS

Revenue

Revenue & Expenses

QTTB has released its 2025 Q4 earnings report, with revenue of 53.74M, reflecting a YoY change of NaN%, and net profit of 57.73M, showing a YoY change of 506.86%. The Sankey diagram below clearly presents QTTB's revenue sources and cost distribution.

Key Indicators

Q32 Bio (QTTB) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Q32 Bio (QTTB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Q32 Bio (QTTB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Q32 Bio (QTTB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown